New ESMO Open editorial on Immunotherapy in breast cancer

ESMO Open shared a recent article by Paola Zagami on X:

“Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing?”

Dario Trapani shared a post on X:

“Don’t miss the new ESMO Open editorial on Immunotherapy in breast cancer.”

Title: Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing?

Authors: P. Zagami, J. Cortés, L.A. Carey and G. Curigliano.

Source: ESMO Open/X and Dario Trapani/X

Dario Trapani is a medical oncologist at the European Institute of Oncology (IEO) and a researcher in the Department of Oncology and Hemato-oncology at the University of Milan. He previously served as a Postdoctoral Researcher at the Dana-Farber Cancer Institute and is focused on population health research.